CMS modifies anti-cancer compendia rules
Executive Summary
CMS slightly modifies the timeline for addition and deletion of compendia approved for use by Medicare Part B contractors in making local coverage decisions for off-label cancer drugs and biologicals from the 2008 proposed physician fee schedule update rule (1"The Pink Sheet" July 9, 2007, p. 13). According to the final rule, CMS will not publish an annual notice for formal requests to update the approved list of compendia, but will annually open a 30-day window on Jan. 15 for submissions. The agency says it expects to post submissions by March 15 on its Web site for a 30-day public notice and comment period...